Drugs / Aclidinium/formoterol
last change Oct 2022 re-read 2 minutes ago

Aclidinium/formoterol

Developed for
chronic obstructive pulmonary disease
Investigated by
Università degli Studi di Ferrara

Trials 1 · a red edge is where a trial was stopped

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03662711 Nov 2018 → Oct 2022 chronic obstructive pulmonary disease Università degli Studi di Ferrara Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Aclidinium/formoterol Aclidinium/formoterolNCT03662711